Discovery and development of novel melanogenic drugs. Melanotan-I and -II

Pharm Biotechnol. 1998:11:575-95. doi: 10.1007/0-306-47384-4_25.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Anticarcinogenic Agents / pharmacology*
  • Drug Design
  • Humans
  • Molecular Sequence Data
  • Peptides, Cyclic / pharmacokinetics
  • Peptides, Cyclic / pharmacology*
  • Peptides, Cyclic / therapeutic use
  • Structure-Activity Relationship
  • alpha-MSH / analogs & derivatives*
  • alpha-MSH / pharmacokinetics
  • alpha-MSH / pharmacology
  • alpha-MSH / therapeutic use

Substances

  • Anticarcinogenic Agents
  • Peptides, Cyclic
  • melanotan-II
  • alpha-MSH
  • MSH, 4-Nle-7-Phe-alpha-